Fasudil reduces GFAP expression after hypoxic injury.

Neuroscience letters (2014-06-07)
Varun Kesherwani, Shikha Tarang, Robert Barnes, Sandeep K Agrawal
摘要

Fasudil (HA-1077), a specific Rho kinase II (ROCKII) inhibitor, is in clinical trials for recovery from spinal cord injury (SCI). The primary role of Fasudil is in axonal regeneration, as it inhibits ROCKII, the key signaling molecule involved in collapse of axon growth cone. Astrogliosis, due to the activation of astrocytes is an indicator of CNS injury. In early stages of injury, GFAP expression increases, helping to restore the integrity of the CNS. An increase in GFAP expression is also a marker of astrogliosis. Thus, reducing GFAP and hence astrogliosis at later stages of SCI is important for neuroregeneration and functional recovery. CoCl2 was used to induce hypoxic injury in astrocytic cell lines A172 (24h) and in spinal cord dorsal column white matter (8h). Several different techniques were used to study the changes in GFAP expression such as real-time PCR, western blotting and immunofluorescence staining with confocal microscopy. Hypoxia increased the expression of GFAP in A172 cells and in the spinal cord dorsal column after CoCl2 (100μM) treatment for 24h and 8h, respectively. We observed 11 folds increase in protein expression in A172 cells (24h) and 4.5 folds in spinal cord dorsal column (8h). The RNA expression was increased 3 folds in A172 cells after 24h of treatment and 4 folds in spinal cord dorsal column after 8h of treatment with 100μM CoCl2. Treatment with fasudil (20μM) significantly reduces the expression of GFAP in A172 cells and in spinal cord dorsal column. Fasudil also decreased activation of NF-κB in A172 cells after hypoxic injury. In the present study, we observed that fasudil reduces the expression of GFAP (consequently, astrogliosis) after hypoxic injury to A172 cells and spinal cord dorsal column. Our studies demonstrate that fasudil also plays a role in GFAP expression by reducing NF-κB activation at the injury site which could further help in axonal regeneration.

材料
货号
品牌
产品描述

Sigma-Aldrich
Trizma ® 碱, Primary Standard and Buffer, ≥99.9% (titration), crystalline
Sigma-Aldrich
叠氮化钠, ReagentPlus®, ≥99.5%
Sigma-Aldrich
羟乙基哌嗪乙硫磺酸, ≥99.5% (titration)
Sigma-Aldrich
蔗糖, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
羟乙基哌嗪乙硫磺酸, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
三氯乙酸, ACS reagent, ≥99.0%
Sigma-Aldrich
三(羟甲基)氨基甲烷, ACS reagent, ≥99.8%
Sigma-Aldrich
四甲基乙二胺, BioReagent, suitable for electrophoresis, ~99%
Sigma-Aldrich
Trizma ® 碱, BioPerformance Certified, meets EP, USP testing specifications, suitable for cell culture, ≥99.9% (titration)
Sigma-Aldrich
5,5'-二硫代双(2-硝基苯甲酸), ≥98%, BioReagent, suitable for determination of sulfhydryl groups
Sigma-Aldrich
蔗糖, ≥99.5% (GC)
Sigma-Aldrich
乙二胺四乙酸 溶液, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
Sigma-Aldrich
乙二胺四乙酸, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
蔗糖, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
苯甲磺酰氟, ≥98.5% (GC)
Sigma-Aldrich
N,N′-亚甲基双丙烯酰胺, 99%
Sigma-Aldrich
乙二胺四乙酸, anhydrous, BioUltra, ≥99% (titration)
Sigma-Aldrich
蔗糖, BioUltra, for molecular biology, ≥99.5% (HPLC)
Sigma-Aldrich
蔗糖, ≥99.5%
Sigma-Aldrich
Trizma ® 碱, BioUltra, for molecular biology, ≥99.8% (T)
Sigma-Aldrich
三氯乙酸 溶液, 6.1 N
Sigma-Aldrich
HEPES缓冲溶液, 1 M in H2O
Supelco
蔗糖, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
蔗糖, puriss., meets analytical specification of Ph. Eur., BP, NF
Sigma-Aldrich
Sigma 7-9®®, ≥99% (titration), crystalline
Sigma-Aldrich
氯化钴 六水合物, ACS reagent, 98%
Sigma-Aldrich
氯化钴 六水合物, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
叠氮化钠, BioXtra
Sigma-Aldrich
四甲基乙二胺, ReagentPlus®, 99%
Sigma-Aldrich
四甲基乙二胺, ≥99.5%, purified by redistillation